B2TYA8 AF NFT

Multidrug resistance protein MdtB

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeibngw6v5fzrvrppb5hiad5bg4tbgckkodvwxobn5gwj6bnod6zc5u/metadata.json
IPFS of structure file: 
bafybeidtzq37vljgo6pa3rdgxc3dyi4zl5poa2vsf2g5d2qt6fstc7ztem/AF-B2TYA8-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x301437AEb4a9d7100Ad0D7b67830522a5E0Ab5e9
First NFT owner address (bech32): 
genesis1xq2r0t4548t3qzks67m8svzj9f0q4d0fx803qm
Current NFT ID #228063 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
228063
Accession (UniProt):
B2TYA8
Name::
Multidrug resistance protein MdtB
Experimental Method:
Predicted structure
Sequence source:
Shigella boydii serotype 18 (strain CDC 3083-94 / BS512)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2TYA8 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2TYA8|MDTB_SHIB3 Multidrug resistance protein MdtB OS=Shigella boydii serotype 18 (strain CDC 3083-94 / BS512) OX=344609 GN=mdtB PE=3 SV=1 MQVLPPSSTGGPSRLFIMRPVATTLLMVAILLAGIIGYRALPVSALPEVDYPTIQVVTLYPGASPDVMTSAVTAPLERQFGQMSGLKQMSSQSSGGASVITLQFQLTLPLDVAEQEVQAAINAATNLLPSDLPNPPVYSKVNPADPPIMTLAVTSTAMPMTQVEDMVETRVAQKISQISGVGLVTLSGGQRPAVRVKLNAQAIAALGLTSETVRTAITGANVNSAKGSLDGPSRAVTLSANDQMQSAEEYRQLIIAYQNGAPIRLGDVATVEQGAENSWLGAWANKEQAIVMNVQRQPGANIISTADSIRQMLPQLTESLPKSVEVTVLSDRTTNIRASVDDTQCELMMAIALVVMIIYLFLRNIPATIIPGVAVPLSLIGTFAVMVFLDFSINNLTLMALTIATGFVVDDAIVVIENISRYIEKGEKPLAAALKGAGEIGFTIISLTFSLIAVLIPLLFMGDIVGRLFREFAITLAVAILISAVVSLTLTPMMCARMLSQESLRKQNRFSRASEKMFDRIIAAYGRGLAKVLNHPWLTLSVALSTLLLSVLLWVFIPKGFFPVQDNGIIQGTLQAPQSSSFANMAQRQRQVADVILQDPAVQSLTSFVGVDGTNPSLNSARLQINLKPLDERDDRVQKVIARLQTAVDKVPGVDLFLQPTQDLTIDTQVSRTQYQFTLQATSLDALSTWVPQLMEKLQQLPQLSDVSSDWQDKGLVAYVNVDRDSASRLGISMADVDNALYNAFGQRLISTIYTQANQYRVVLEHNTENTPGLAALGTIRLTSSDGGVVPLSSIAKIEQRFAPLSINHLDQFPVTTISFNVPDNYSLGDAVQAIMDTEKTLNLPVDITTQFQGCTLAFQSALGSTVWLIVAAVVAMYIVLGILYESFIHPITILSTLPTAGVGALLALMIAGSELDVIAIIGIILLIGIVKKNAIMMIDFALAAEREQGMSPRDAIYQACLLRFRPILMTTLAALLGALPLMLSTGVGAELRRPLGIGMVGGLVVSQVLTLFTTPVIYLLFDRLALWTKSRFACHEEEA